NF Trinity Capital Portfolio holdings
Top Buys
| 1 |
JD.com
JD
|
+$17.6M |
| 2 |
NXP Semiconductors
NXPI
|
+$11.6M |
| 3 |
Booking.com
BKNG
|
+$9.83M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$8.05M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
+$7.65M |
Top Sells
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$13.8M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$10.3M |
| 3 |
Mastercard
MA
|
+$9.8M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$7.76M |
| 5 |
Meta Platforms (Facebook)
META
|
+$5.31M |
Sector Composition
| 1 | Communication Services | 24.96% |
| 2 | Consumer Discretionary | 22.77% |
| 3 | Technology | 17.4% |
| 4 | Healthcare | 14.13% |
| 5 | Financials | 10.13% |
Similar funds
NF Trinity Capital's Q4 2017 Portfolio in Review
As of Q4 2017, NF Trinity Capital held 62 positions worth $769M, up 9.7% from $700M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
NF Trinity Capital deployed $38.3M of net new capital in Q4 2017, opening 14 new positions and adding to 7 existing holdings. Its largest new stake was Booking.com: 135,750 shares worth $9.44M.
By sector, the portfolio is most concentrated in Communication Services at 25% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was iShares Biotechnology ETF, an estimated $10.3M trimmed.
- NF Trinity Capital's largest Q4 2017 buy was Booking.com: 135,750 shares worth $9.44M.
- NF Trinity Capital added most to JD.com in Q4 2017, an estimated $17.6M increase.
- NF Trinity Capital's biggest Q4 2017 reduction was iShares Biotechnology ETF, cutting an estimated $10.3M.
- NF Trinity Capital fully exited State Street Health Care Select Sector SPDR ETF in Q4 2017, selling an estimated $13.8M.
- NF Trinity Capital's ten largest holdings make up 63% of its $769M portfolio in Q4 2017.
- NF Trinity Capital opened 14 new positions and closed 5 in Q4 2017.
- NF Trinity Capital's portfolio value rose 9.7% quarter-over-quarter to $769M.
Based on NF Trinity Capital's 13F filing for Q4 2017, filed 6 Feb 2018.